Literature DB >> 12084043

Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.

Andrea Henriques-Pons1, Gabriel M Oliveira, Mauricio M Paiva, Alexandre F S Correa, Marcos M Batista, Rodrigo C Bisaggio, Chau-Ching Liu, Vinicius Cotta-De-Almeida, Claudia M L M Coutinho, Pedro M Persechini, Tania C Araujo-Jorge.   

Abstract

CD8+ T lymphocytes are considered an important cell population involved in the control of parasitaemia and mortality after Trypanosoma cruzi infection. However, despite recent developments in this field, the mechanism whereby this control is exerted is still not completely understood. Here we have used perforin knockout (-/-) mice infected with Y strain T. cruzi in order to evaluate specifically the participation of the perforin-based cytotoxic pathway in the destruction of cardiomyocytes, cellular inflammatory infiltration, and control of parasitaemia and mortality. We observed that although parasitaemia was equivalent in perforin (+/+) and (-/-) groups, survival rate and spontaneous physical performance were significantly lower in the perforin deficient mice. The cardiac inflammatory cell infiltration, mostly composed of CD8+ cells, was more evident in perforin (-/-) mice. Ultrastructural and immunofluorescence analysis, as well as plasma creatine kinase activity, revealed cardiomyocyte damage and necrosis, more evident in perforin (-/-) mice. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assays performed in heart samples revealed similar and modest levels of apoptosis in both perforin (+/+) and (-/-) mice. These results indicate that perforin does not play a pivotal role in the control of parasitaemia and direct lysis of cardiomyocytes, but seems to be an important molecule involved in the control of cardiac inflammation and pathology induced by a highly virulent strain of T. cruzi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084043      PMCID: PMC2517672          DOI: 10.1046/j.1365-2613.2002.00215.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  46 in total

1.  Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses.

Authors:  P M Minoprio; H Eisen; L Forni; M R D'Imperio Lima; M Joskowicz; A Coutinho
Journal:  Scand J Immunol       Date:  1986-12       Impact factor: 3.487

2.  The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.

Authors:  J D Young; Z A Cohn; E R Podack
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

3.  Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.

Authors:  R L Tarleton
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

4.  Experimental infection with Trypanosoma cruzi (Chagas' disease): a model of acute and chronic myocardiopathy.

Authors:  W H Abelmann
Journal:  Ann N Y Acad Sci       Date:  1969-01-31       Impact factor: 5.691

5.  Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells.

Authors:  M Russo; N Starobinas; P Minoprio; A Coutinho; M Hontebeyrie-Joskowicz
Journal:  Ann Inst Pasteur Immunol       Date:  1988 May-Jun

6.  The effect of immuno-depression due to neonatal thymectomy on infections with Trypanosoma cruzi in mice.

Authors:  G A Schmunis; S M Cappa; O C Traversa; J F Janovsky
Journal:  Trans R Soc Trop Med Hyg       Date:  1971       Impact factor: 2.184

7.  Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy.

Authors:  A P de Souza; B P Olivieri; S L de Castro; T C Araújo-Jorge
Journal:  Parasitol Res       Date:  2000-10       Impact factor: 2.289

8.  Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

Authors:  B Motyka; G Korbutt; M J Pinkoski; J A Heibein; A Caputo; M Hobman; M Barry; I Shostak; T Sawchuk; C F Holmes; J Gauldie; R C Bleackley
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

9.  Trypanosoma cruzi: the effect of variations in experimental conditions on the levels of macrophage infection in vitro.

Authors:  T C Araújo-Jorge; E P Sampaio; W De Souza; M de N Meirelles
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

10.  Purified perforin induces target cell lysis but not DNA fragmentation.

Authors:  R C Duke; P M Persechini; S Chang; C C Liu; J J Cohen; J D Young
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  12 in total

1.  Experimental infection with Trypanosoma cruzi increases the population of CD8(+), but not CD4(+), immunoglobulin G Fc receptor-positive T lymphocytes.

Authors:  Andrea Henriques-Pons; Bianca P Olivieri; Gabriel M Oliveira; Marc Daëron; Tania C de Araújo-Jorge
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.

Authors:  Fanny Tzelepis; Bruna C G de Alencar; Marcus L O Penido; Ricardo T Gazzinelli; Pedro M Persechini; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

3.  Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection.

Authors:  Gabriel Melo de Oliveira; Rafaela Lopes Diniz; Wanderson Batista; Marcelo Meuser Batista; Cristiane Bani Correa; Tânia Cremonini de Araújo-Jorge; Andréa Henriques-Pons
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

4.  Mast cell function and death in Trypanosoma cruzi infection.

Authors:  Marcelo Meuser-Batista; José Raimundo Corrêa; Vinícius Frias Carvalho; Constança Felícia De Paoli de Carvalho Britto; Otacilio da Cruz Moreira; Marcos Meuser Batista; Maurílio José Soares; Francisco Alves Farias Filho; Patrícia Machado R E Silva; Joseli Lannes-Vieira; Robson Coutinho Silva; Andrea Henriques-Pons
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

5.  Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection.

Authors:  Bianca Perdigão Olivieri; Vinícius Cotta-De-Almeida; Tania Araújo-Jorge
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Specific antibodies induce apoptosis in Trypanosoma cruzi epimastigotes.

Authors:  Ana María Fernández-Presas; Patricia Tato; Ingeborg Becker; Sandra Solano; Natalia Copitin; Natalia Kopitin; Miriam Berzunza; Kaethe Willms; Joselin Hernández; José Luis Molinari
Journal:  Parasitol Res       Date:  2010-03-18       Impact factor: 2.289

7.  Rapamycin Treatment Reduces Acute Myocarditis Induced by Trypanosoma cruzi Infection.

Authors:  Thabata L A Duque; Cynthia M Cascabulho; Gabriel M Oliveira; Andrea Henriques-Pons; Rubem F S Menna-Barreto
Journal:  J Innate Immun       Date:  2019-12-04       Impact factor: 7.349

8.  In the Acute Phase of Trypanosoma cruzi Infection, Liver Lymphoid and Myeloid Cells Display an Ambiguous Phenotype Combining Pro- and Anti-Inflammatory Markers.

Authors:  Carina de Lima Pereira Dos Santos; Natalia Vacani-Martins; Cynthia Machado Cascabulho; Mirian Claudia de Souza Pereira; Ian Nicholas Crispe; Andrea Henriques-Pons
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

9.  Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection.

Authors:  Andréa P de Souza; Gabriel Melo de Oliveira; Jean Vanderpas; Solange L de Castro; Maria Teresa Rivera; Tania C Araújo-Jorge
Journal:  Parasitol Res       Date:  2003-07-22       Impact factor: 2.289

10.  Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Authors:  Jaline Coutinho Silverio; Luzia Maria de-Oliveira-Pinto; Andréa Alice da Silva; Gabriel Melo de Oliveira; Joseli Lannes-Vieira
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.